SBRA
Sabra Health Care REIT, Inc. · Real Estate · REIT - Healthcare Facilities
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 129 | -1 | 188.62M | $3.68B | +4 | −6 |
| Q1 2026 | 134 | +4 | 191.42M | $3.68B | +8 | −5 |
| Q4 2025 | 129 | -1 | 205.98M | $3.90B | +1 | −1 |
| Q3 2025 | 20 | +3 | 111.66M | $2.08B | +4 | −2 |
| Q2 2025 | 15 | 0 | 102.69M | $1.89B | — | — |
| Q1 2025 | 12 | 0 | 29.15M | $509.24M | — | — |
| Q4 2024 | 12 | -2 | 28.92M | $500.79M | — | −2 |
| Q3 2024 | 13 | 0 | 18.67M | $347.37M | — | — |
| Q2 2024 | 13 | — | 16.61M | $255.71M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 6.19M | — | $95.35M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Norges Bank ✦ (passive) | 2.78M | — | $42.80M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 2.56M | — | $39.37M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Point72 Asset Management ✦ | 1.73M | — | $26.68M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 1.29M | — | $19.82M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 842.33K | — | $12.97M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 435.77K | — | $6.63M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 308.24K | — | $4.75M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 286.53K | — | $4.41M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | T. Rowe Price ✦ | 130.03K | — | $2.00M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 24.74K | — | $380,934 | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 20.33K | — | $313,082 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 14.91K | — | $229,614 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 456 holders, 250.11M shares, $4.68B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 200.00K sh · $4.17M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology